Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date
Article in Expert Opinion on Therapeutic Patents (July 2024)
The most recent citing publications are shown below. View all 53 publications that cite this research output on Dimensions.
Article in Expert Opinion on Therapeutic Patents (July 2024)
Article in Journal of Parkinson's Disease (April 2024)
Article in npj Parkinson's Disease (March 2024)